Search Results - "Causse, Xavier"
-
1
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients
Published in Journal of hepatology (01-01-2017)“…Graphical abstract…”
Get full text
Journal Article -
2
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France
Published in Digestive diseases and sciences (01-10-2016)“…Background and Aims Tenofovir disoproxil fumarate (TDF) demonstrated potent and sustainable antiviral efficacy and a good safety profile in patients with…”
Get full text
Journal Article -
3
International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations
Published in BMC gastroenterology (12-09-2023)“…Abstract Background The Hepatic hydrothorax is a pleural effusion related to portal hypertension; its diagnosis and therapeutic management may be difficult…”
Get full text
Journal Article -
4
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study
Published in Clinics and research in hepatology and gastroenterology (01-09-2021)“…•We explored the pathways leading to hepatocellular carcinoma in hepatitis B disease.•The relationships between clinical characteristics and the cancer were…”
Get full text
Journal Article -
5
Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort
Published in JHEP reports (01-08-2024)“…In France, bulevirtide (BLV) became available in September 2019 through an early access program to treat patients with HDV. The aim of this analysis was to…”
Get full text
Journal Article -
6
Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort
Published in BMC infectious diseases (02-04-2019)“…Although real-life results of sofosbuvir/simeprevir have been extensively reported from the United States, data from other geographical areas are limited. In…”
Get full text
Journal Article -
7
An observational, prospective, multicenter study on the utilization and effectiveness of elbasvir–grazoprevir treatment association for chronic hepatitis C in France (ZEPHYR study)
Published in Health science reports (01-01-2023)“…Background and Aim The efficacy and safety profiles of elbasvir–grazoprevir (EBR/GZR) has been established in more than 10 clinical trials. However, the…”
Get full text
Journal Article -
8
Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting Antivirals
Published in Annals of hepatology (2019)“…AbstractIntroduction and aimData on the efficacy and tolerance of interferon-free treatment in chronic hepatitis C (CHC) in elderly patients are limited in…”
Get full text
Journal Article -
9
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
Published in The Lancet (British edition) (06-04-2019)“…Although direct-acting antivirals have been used extensively to treat patients with chronic hepatitis C virus (HCV) infection, their clinical effectiveness has…”
Get full text
Journal Article -
10
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta
Published in Journal of hepatology (01-11-2020)“…HDV infection causes severe chronic liver disease in individuals infected with HBV. However, the factors associated with poor prognosis are largely unknown…”
Get full text
Journal Article -
11
Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial
Published in Journal of hepatology (01-04-2015)“…Background & Aims Albumin infusion improves renal function and survival in cirrhotic patients with spontaneous bacterial peritonitis (SBP) but its efficacy in…”
Get full text
Journal Article -
12
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890
Published in Journal of hepatology (01-09-2013)“…Background & Aims In phase III trials, the safety profile of triple therapy (pegylated interferon/ribavirin with boceprevir or telaprevir) seems to be similar…”
Get full text
Journal Article -
13
SAT-052 Artificial intelligence and liver transplantation: posttransplantation chronic kidney disease prediction
Published in Journal of hepatology (01-06-2024)Get full text
Journal Article -
14
Hepatitis B Delta: assesment of knowledge and practices of French non academic hepato-gastroenterologists
Published in Journal of hepatology (01-07-2022)Get full text
Journal Article -
15
Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis
Published in Gastroenterology (New York, N.Y. 1943) (01-07-2014)“…Background & Aims We investigated the effectiveness of the protease inhibitors peginterferon and ribavirin in treatment-experienced patients with hepatitis C…”
Get full text
Journal Article -
16
Extensive splanchnic vein thrombosis after SARS-CoV-2 vaccination: A Vascular Liver Disease Group (VALDIG) initiative
Published in Hepatology (Baltimore, Md.) (01-11-2024)“…Since the introduction of SARS-CoV-2 vaccines, several cases of vaccine-induced immune thrombocytopenia and thrombosis (VITT) have been described, especially…”
Get full text
Journal Article -
17
Management of primary biliary cholangitis: results from a large real-life observational study in France and Belgium
Published in European journal of gastroenterology & hepatology (01-12-2021)“…BACKGROUND AND AIMS:To assess the characteristics, care, treatment response, and outcomes of primary biliary cholangitis (PBC) patients recently followed-up by…”
Get full text
Journal Article -
18
Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: A large multicentre audit with real-life results
Published in Journal of hepatology (01-01-2018)“…[Display omitted] •One-third of the patients with cirrhosis and variceal bleeding are eligible for early-TIPS.•TIPS is restricted to 7% of patients displaying…”
Get full text
Journal Article -
19
Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study
Published in Cancer (01-05-2018)“…BACKGROUND Recent data suggest that alcohol‐related hepatocellular carcinoma (HCC) is diagnosed at a later stage. The aim of this study was to compare HCC…”
Get full text
Journal Article -
20